Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3851
ProQR Therapeutics
PRQR
$205M
| $67K | ﹤0.01% |
12,997
+1,409
| +12% | +$7K |
2016 Q2
4 quarters
|
|
|
ONCS
3852
DELISTED
OncoSec Medical Incorporated
ONCS
| $67K | ﹤0.01% |
259
| – | – |
2015 Q3
7 quarters
|
|
3853
Eldorado Gold
EGO
$9B
| $66K | ﹤0.01% |
5,091
-63,678
| -93% | -$1.04M |
2017 Q1
1 quarter
|
|
|
CHMA
3854
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $66K | ﹤0.01% |
45,638
-2,832
| -6% | -$4.29K |
2015 Q3
7 quarters
|
|
|
OCRX
3855
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $66K | ﹤0.01% |
57,658
-3,970
| -6% | -$4.61K |
2014 Q3
11 quarters
|
|
|
IEC
3856
DELISTED
IEC Electronics Corp.
IEC
| $65K | ﹤0.01% |
18,187
| – | – |
2013 Q2
16 quarters
|
|
|
GLBR
3857
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $65K | ﹤0.01% |
32,820
| – | – |
2013 Q2
16 quarters
|
|
3858
China Automotive Systems
CAAS
$133M
| $64K | ﹤0.01% |
13,333
-4,226
| -24% | -$20.5K |
2015 Q1
9 quarters
|
|
3859
Smith Micro Software
SMSI
$13.4M
| $64K | ﹤0.01% |
1,108
-25
| -2% | -$1.09K |
2013 Q2
16 quarters
|
|
3860
Tenax Therapeutics
TENX
$58.4M
| $64K | ﹤0.01% |
3
| – | – |
2014 Q1
13 quarters
|
|
|
TCON
3861
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $64K | ﹤0.01% |
135
-9
| -6% | -$5.49K |
2015 Q2
8 quarters
|
|
|
IMI
3862
DELISTED
Intermolecular, Inc.
IMI
| $64K | ﹤0.01% |
69,386
-10,585
| -13% | -$9.25K |
2013 Q2
16 quarters
|
|
|
GLA
3863
DELISTED
GlassBridge Enterprises, Inc.
GLA
| $63K | ﹤0.01% |
16,103
| – | – |
2017 Q1
1 quarter
|
|
3864
Vince Holding Corp
VNCE
$152M
| $62K | ﹤0.01% |
13,183
-3,417
| -21% | -$24.4K |
2013 Q4
14 quarters
|
|
3865
Westport Fuel Systems
WPRT
$34.2M
| $62K | ﹤0.01% |
2,654
-1,203
| -31% | -$18.8K |
2013 Q2
16 quarters
|
|
3866
AmeriServ Financial
ASRV
$74.2M
| $61K | ﹤0.01% |
14,728
| – | – |
2013 Q2
16 quarters
|
|
3867
Riot Platforms
RIOT
$5.66B
| $61K | ﹤0.01% |
15,089
| – | – |
2013 Q2
16 quarters
|
|
3868
DELISTED
Repros Therapeutics Inc.
RPRX
| $60K | ﹤0.01% |
131,112
-2,564
| -2% | -$1.86K |
2013 Q2
16 quarters
|
|
3869
DELISTED
Evoke Pharma
EVOK
| $59K | ﹤0.01% |
160
| – | – |
2014 Q1
13 quarters
|
|
3870
Full House Resorts
FLL
$37.4M
| $59K | ﹤0.01% |
24,413
| – | – |
2013 Q2
16 quarters
|
|
|
KSPN
3871
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $59K | ﹤0.01% |
1,788
-523
| -23% | -$18.3K |
2013 Q2
16 quarters
|
|
3872
Gyre Therapeutics
GYRE
$700M
| $57K | ﹤0.01% |
+1,658
| New | +$59.5K |
2017 Q2
0 quarters
|
|
|
ESES
3873
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
| $57K | ﹤0.01% |
45,860
| – | – |
2015 Q3
7 quarters
|
|
3874
DELISTED
LogicMark
LGMK
| $56K | ﹤0.01% |
6
| – | – |
2014 Q4
10 quarters
|
|
3875
Senstar Technologies
SNT
$32.9M
| $56K | ﹤0.01% |
11,406
-1,478
| -11% | -$8.7K |
2017 Q1
1 quarter
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.